NSE · Healthcare · Diagnostics & Research
EPS came in at 2.73 against a street estimate of 2.65 — a beat of 3.0%.
with an average price target of ₹658.16.
| Document | Date |
|---|---|
| Q1 FY27 earnings call METROPOLIS HEALTHCARE LIMITED – INVESTOR SUMMARY HEADLINE NUMBERS • Revenue FY2026: INR 1,646 crores (57% B2C, 43% B2B) • 3-year revenue CAGR (FY202 | 2026-09-02 |
| Investor presentation · Q1 FY27 METROPOLIS HEALTHCARE LIMITED – INVESTOR SUMMARY HEADLINE NUMBERS • FY26 Revenue: ₹1,646 Cr – 23.6% growth YoY; 17.6% CAGR over FY24-26 • FY26 EBITD | 2026-08-27 |
| Quarterly results · Q1 FY27 METROPOLIS HEALTHCARE LIMITED – Q1 FY2027 RESULTS SUMMARY HEADLINE NUMBERS STANDALONE (Parent Company Only) • Revenue from operations: Rs 3,722.84 m | 2026-08-04 |
| Investor presentation | 2026-08-04 |
| Annual report FY2026 METROPOLIS HEALTHCARE LIMITED - FY 2025-26 ANNUAL REPORT SUMMARY HEADLINE NUMBERS • Market Capitalisation: ₹8,993 crore as of March 31, 2026 • Reven | 2026-07-27 |
| Q4 FY26 earnings call METROPOLIS HEALTHCARE LIMITED – Q4 FY26 SUMMARY HEADLINE NUMBERS • Q4 FY26 MHL Group revenue: INR 425 crores (23% YoY growth); organic revenue: INR | 2026-05-19 |
| Investor presentation · Q4 FY26 METROPOLIS HEALTHCARE LIMITED – Q4 & FY26 SUMMARY HEADLINE NUMBERS • FY26 Revenue (MHL Group): INR 1,646 Cr, +24% YoY • FY26 EBITDA (MHL Group): INR | 2026-05-13 |
| Quarterly results · Q4 FY26 METROPOLIS HEALTHCARE LIMITED – FINANCIAL SUMMARY Board Meeting Outcome, May 13, 2026 --- HEADLINE NUMBERS • FY 2025-26 Standalone Revenue from Ope | 2026-05-13 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | ₹1 / share ex-date May 19, 2026 | 2026-05-19 |
| Bonus issue | 3 : 1 ex-date Mar 20, 2026 | 2026-03-20 |
| Dividend | ₹4 / share ex-date Nov 11, 2025 | 2025-11-11 |
| Announcement | Date |
|---|---|
| 2nd interim dividend of Re. 1 per equity share declared Metropolis Healthcare Limited announced a second interim dividend of Re. 1 per equity share, approved by the Board of Directors on May 13, 2026. This means each shareholder will receive one | 2026-05-13 |
| Interim dividend of Rs. 4 per equity share declared Metropolis Healthcare Limited's Board of Directors declared an interim dividend of Rs. 4 per equity share on November 4, 2025. What Happened: The company announced it will distribute cash t | 2025-11-04 |
| Acquires Ambika Pathology Laboratory, strengthening presence in Western Maharashtra Metropolis Healthcare Limited, a leading diagnostic chain in India, has acquired Ambika Pathology Laboratory in Kolhapur, Maharashtra. This strategic acquisition strengthens the company's pr | 2025-09-18 |
| Completion of acquisition by Metropolis Healthcare Limited Metropolis Healthcare Limited has informed the Exchange about completion of acquisition | 2025-09-18 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Metropolis Healthcare Limited — free to start.
Google PlayApp StoreData updated 2026-09-18.